NCT03506932
- Conditions
- Glucose Metabolism Disorders, Hyperinsulinism, Insulin Resistance, +3 more
- Locations
-
- I. H. Asper Clinical Research Institute Winnipeg, Manitoba, Canada
Clinical trial condition
Explore clinical trials studying Post-prandial Glycaemic Response. Study availability and eligibility vary by location and protocol.
NCT03506932
NCT06757608
NCT03306927
NCT03306706